Amy Hanlon Newell

Director, Global Medical Affairs Oncology, Biomarkers, and Cdx @Daiichi Sankyo US

Tucson, AZ, US
MOBILE NUMBERS
+15•••••••10

Signup · Get unlimited contacts

WORK HISTORY

Aug 2022 — Present

Director, Global Medical Affairs Oncology, Biomarkers, and Cdx @Daiichi Sankyo US

View department →

Remote from Tucson, AZ, US

Drive development of GMA strategies and tactics for oncology therapies related to biomarkers and CDx-Biomarker and CDx lead for GMA evidence generation studies/projects-Lead global precision medical affairs team in stakeholder engagement to facilitate medical input and activities related to biomarkers and CDx

EDUCATION

1993 — 1997

Massachusetts Institute of Technology

B.S., Biology

1999 — 2005

Oregon Health & Science University

Ph.D., Molecular and Medical Genetics

SKILLS

ImmunofluorescenceImmunohistochemistryCytogeneticsTeachingDiagnoseOncology GeneticsFish Assay DevelopmentGenomicsMolecular DiagnosticsMolecular BiologyDnaGeneticsWestern BlottingAssay DevelopmentCellCancerFishTissue CultureElisaCompanion Diagnostics

ABOUT AMY HANLON NEWELL

Dynamic, adaptable, and effective molecular diagnostics expert with specialty focus in oncology and companion diagnostics. With over 15 years experience, a Medical Affairs and Clinical Science Leader specializing in scientific strategy for on-market and approaching-market diagnositic products including study and publication plan strategy, scientific and key opinion leader communications, pathologist training and education, symposia, and advisory boards. 5+years experience of developing molecular diagnostic tests in clinical research laboratory for application and transition to clinical diagnostics laboratory.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Amy Hanlon Newell — Email, Phone Number & Contact Info | Unifers